SunTrust Robinson Humphrey
https://www.suntrustrh.com/r.ashx?pid=3SunTrust Robinson Humphrey is the investment banking division of SunTrust Banks (NYSE: STI). To serve the needs of corporate clients across the nation, the firm’s services include capital raising, strategic advisory, risk management, and investment solutions. It also offers fixed income, equity research, and sales and trading to institutional investors.
View Older Stories View More Recent Stories
-
SunTrust Starts Cellectis (CLLS) at Buy
-
SunTrust Starts Mirati Therapeutics (MRTX) at Buy
-
SunTrust Starts Curis (CRIS) at Buy
-
SunTrust Starts Tesaro (TSRO) at Buy
-
Rex Energy (REXX) Enters $175M Joint Exploration, Development Agreement with Benefit Street Partners
-
Rex Energy Announces $175 Million Joint Exploration and Development Agreement in Moraine East and Warrior North Operated Areas
-
HCA Announces Proposed Public Offering of $1.0 Billion Senior Secured Notes
-
Notable Analyst Rating Changes 2/26: (ACHN) (NFX) (STAG) Upgraded; (BBY) (VIPS) (GG) Downgraded
-
SunTrust Downgrades Patriot National (PN) to Neutral
-
SunTrust Upgrades Newfield Exploration (NFX) to Buy
-
SunTrust Starts Crown Castle (CCI) at Buy
-
SunTrust Downgrades EQT Corp. (EQT) to Neutral
-
Orchid Island Capital Announces Fourth Quarter 2015 Results
-
SunTrust Downgrades Dril-Quip (DRQ) to Neutral
-
SunTrust Downgrades Cracker Barrel (CBRL) to Neutral
-
CyrusOne Reports Fourth Quarter 2015 Earnings
-
Time Inc explores bid for Yahoo's core business: source
-
Fitbit (FIT) PT Cut to $20 by SunTrust's Peck; 'Buy' Maintained
-
Magellan Midstream Prices $650 Million Debt Offering
-
Belden to Participate in Upcoming Investor Events
-
Protalix BioTherapeutics to Participate in the SunTrust Robinson Humphrey Orphan Drug Day and the 12th Annual WORLDSymposium™ 2016
-
Notable Analyst Rating Changes 2/19: (MDCA) (VRTU) (EQIX) Upgraded; (SUNE) (UPL) (IAG) Downgraded
-
SunTrust Upgrades Virtusa (VRTU) to Buy
-
Catalyst Pharmaceuticals Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug Day
-
Amid Chatter; SunTrust Sees Yahoo! (YHOO) Management Maintaining Fiduciary Duty; Affirms at 'Buy'
-
Notable Analyst Rating Changes 2/18: (SHOP) (CVA) (AMZN) Upgraded; (HRL) (GRMN) (LINE) Downgraded
-
SunTrust Starts Genpact Ltd. (G) at Buy
-
SunTrust Starts GTT Communications (GTT) at Buy
-
Strongbridge Biopharma plc Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug Day
-
Medical Properties Trust Announces Upsizing and Pricing of $500 Million of 6.375% Senior Notes Due 2024 by Its Operating Partnership and MPT Finance Corporation
-
Fitch Rates Lipscomb University, TN Revs at 'BBB'; Outlook Stable
-
Catalyst Pharma's (CPRX) Price Target Trimmed to $6 at SunTrust; 'Buy' Rating Maintained
-
Medical Properties Trust Announces Public Offering of $400 Million of Senior Notes Due 2024
-
Akari Therapeutics to Participate in the 2016 SunTrust Robinson Humphrey Orphan Drug Day
-
Summit Therapeutics to Participate in SunTrust Robinson Humphrey’s 2016 Orphan Drug Day
-
SunTrust Upgrades Antero Resources (AR) to Neutral
-
Zafgen to Participate in Upcoming Investor Conferences
-
WAVE Life Sciences to Present at the SunTrust Robinson Humphrey 2016 Orphan Drug Day Conference
-
Notable Analyst Rating Changes 2/12: (WEB) (CRK) (TIME) Upgraded; (BA) (CSX) (NTAP) Downgraded
-
SunTrust Upgrades Web.com, Inc. (WEB) to Buy
-
Notable Analyst Rating Changes 2/11: (TWX) (BDX) (LVLT) Upgraded; (V) (SEMI) (ARMH) Downgraded
-
SunTrust Starts Square (SQ) at Neutral
-
SunTrust Upgrades NCI, Inc. (NCIT) to Buy
-
SunTrust Downgrades Flowers Foods (FLO) to Neutral
-
Twitter (TWTR) PT Cut to $20 by SunTrust's Peck; 'Buy' Maintained
-
Orchid Island Capital Announces February 2016 Monthly Dividend and January 29, 2016 RMBS Portfolio Characteristics
-
SunTrust Downgrades Ruckus Wireless (RKUS) to Neutral
-
SunTrust Upgrades PrivateBancorp, Inc. (PVTB) to Buy
-
SunTrust Downgrades Brixmor Property (BRX) to Neutral
-
The Ensign Group Announces $250 Million Revolving Credit Facility

